Vaccines | Author Guidelines

Vaccines is an official Open Access, peer-reviewed, scholarly research journal which aims to share the latest and advance information, studies and researches related to Vaccines and vaccination. It publish the most complete and reliable source of information in the mode of original articles, review articles, case reports, short communications, etc. covering all the aspects of Nano Science.

Vaccines journal publishes articles in all aspects of Vaccines and vaccination.

The aims and scope of the journal includes current findings in all areas related to Human Vaccine Trials, Veterinary Vaccines, Cancer Vaccines, Vaccine Adjuvants, Vaccine regulatory issues, Preclinical vaccine studies, Childhood vaccines, HIV vaccines, Malaria vaccines, TB vaccines, etc.,

To submit a new manuscript authors should use the online submission system or through editorial office mail id.

Policy

Vaccines journal publishes original research articles of outstanding medical importance. We will consider manuscripts of any length; we encourage the submission of both substantial full-length bodies of work and shorter manuscripts that report novel findings that might be based on a more limited range of experiments. The writing style should be concise and accessible, avoiding jargon so that the paper is understandable for readers outside a specialty or those whose first language is not English. Editors will make suggestions for how to achieve this, as well as suggestions for cuts or additions that could be made to the article to strengthen the argument. Our aim is to make the editorial process rigorous and consistent, but not intrusive or overbearing. Authors are encouraged to use their own voice and to decide how best to present their ideas, results, and conclusions. Although we encourage submissions from around the globe, we require that manuscripts be submitted in English. Authors who do not use English as a first language may contact us for additional information. As a step towards overcoming language barriers on acceptance of the paper, we encourage authors fluent in other languages to provide copies of their full articles or abstracts in other languages. We will publish these translations as supporting information and list them, together with other supporting information files, at the end of the article text.

Article Processing Charges

Publishing with open access is not without costs. Vaccines journal defrays those costs from article-processing charges (APCs) payable by authors once the manuscript has been accepted for publication. Vaccines journal does not have subscription charges for its research content, believing instead that immediate, world-wide, barrier-free, open access to the full text of research articles is in the best interests of the scientific community.

The basic article processing fee or manuscript handling cost is as per the price mentioned above on the other hand it may vary based on the extensive editing, colored effects, complex equations, extra elongation of no. of pages of the article, etc.